Canada markets closed
  • S&P/TSX

    20,200.65
    +44.29 (+0.22%)
     
  • S&P 500

    4,246.44
    +21.65 (+0.51%)
     
  • DOW

    33,945.58
    +68.61 (+0.20%)
     
  • CAD/USD

    0.8129
    +0.0037 (+0.46%)
     
  • CRUDE OIL

    73.08
    -0.58 (-0.79%)
     
  • BTC-CAD

    40,369.75
    -119.84 (-0.30%)
     
  • CMC Crypto 200

    780.40
    -13.92 (-1.75%)
     
  • GOLD FUTURES

    1,778.20
    -4.70 (-0.26%)
     
  • RUSSELL 2000

    2,295.95
    +9.85 (+0.43%)
     
  • 10-Yr Bond

    1.4720
    -0.0120 (-0.81%)
     
  • NASDAQ

    14,253.27
    +111.79 (+0.79%)
     
  • VOLATILITY

    16.66
    -1.23 (-6.88%)
     
  • FTSE

    7,090.01
    +27.72 (+0.39%)
     
  • NIKKEI 225

    28,884.13
    +873.20 (+3.12%)
     
  • CAD/EUR

    0.6804
    +0.0019 (+0.28%)
     

Federal government under fire for stopping short of U.S. commitment on vaccine waiver

·1 min read

WASHINGTON — Ottawa has yet to follow the United States on easing patent protections for COVID-19 vaccines — and critics and allies alike are noticing.

The One Campaign, a progressive anti-poverty group that has praised Justin Trudeau in the past, calls Canada "oddly absent" from the discussion.

The U.S. agreed Wednesday to so-called text-based negotiations at the World Trade Organization on a possible waiver to the rules.

The idea is to make vaccine formulas and expertise more widely available so more countries could develop their own supply.

Canada expressed support for the U.S. decision, but has so far refused to say whether it would also support the waiver and take part in the talks.

New Democrat Leader Jagmeet Singh is accusing the prime minister of prioritizing drug-company profits over global public health.

This report by The Canadian Press was first published May 6, 2021.

The Canadian Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting